Dose Of Reality: Breaking Down Big Pharma’s Year of Bad Behavior in 2025: Part II: Big Pharma’s DTC Advertising
Dec 29, 2025
Big Pharma’s Aggressive Marketing Directly Targeting Consumers to Boost… Read More
© 2026 CSRXP- All Rights Reserved
Dose of Reality
Dose of Reality: Breaking Down Big Pharma’s Year of Bad Behavior in 2025: Part I: Big Pharma’s Egregious Pricing Practices
Dec 29, 2025
Take a Look Back on Big Pharma’s Year of Price Hikes and Increasingly… Read More
DOSE OF REALITY: STUDY FURTHER HIGHLIGHTS THE COST OF BIG PHARMA’S BLOCKBUSTER BAILOUT
Nov 20, 2025
Analysis Finds Excluding Brand Name Drugs Approved to Treat Rare Diseases from… Read More
DOSE OF REALITY: JAMA NETWORK ANALYSIS SHINES LIGHT ON HOW BIG PHARMA PUSHES SALES OF HIGH-PRICED BLOCKBUSTERS BY TARGETING CONSUMERS ON SOCIAL MEDIA
Nov 19, 2025
Brand Name Drug Companies Sidestep Guardrails Meant to Protect American… Read More
DOSE OF REALITY: NEW ICER REPORT FINDS BIG PHARMA CONTINUES SETTING INCREASINGLY OUT-OF-CONTROL LAUNCH PRICES UNJUSTIFIED BY CLINICAL VALUE
Oct 27, 2025
Launch Prices for 23 New Treatments Exceeding Estimates for a Fair Price Cost… Read More
DOSE OF REALITY: MERCK SURPASSES MILESTONE IN PRODUCT-HOPPING STRATEGY TO BLOCK COMPETITION, KEEP PRICES HIGH ON BLOCKBUSTER CANCER DRUG KEYTRUDA
Oct 22, 2025
DOSE OF REALITY: MERCK SURPASSES MILESTONE IN PRODUCT-HOPPING STRATEGY TO… Read More
DOSE OF REALITY: CONGRESS MUST REPEAL BIG PHARMA’S BLOCKBUSTER BAILOUT THAT WILL COST SENIORS AND TAXPAYERS BILLIONS OF DOLLARS IN PREVIOUSLY UNDERESTIMATED COSTS
Oct 20, 2025
ORPHAN Cures Act Will Enable Big Pharma to Keep Drug Prices High on Top Money… Read More
DOSE OF REALITY: BIG PHARMA’S QUICK DELISTING OF MORE THAN 40 SHAM PATENTS HIGHLIGHTS SCALE OF PATENT THICKETS ON TOP MONEY-MAKERS
Sep 18, 2025
Analysis Finds Brand Name Drug Companies Declined to Even Attempt a Defense of… Read More
DOSE OF REALITY: GENERIC AND BIOSIMILAR COMPETITION GENERATES SIGNIFICANT SAVINGS FOR PATIENTS AND THE U.S. HEALTH CARE SYSTEM
Sep 10, 2025
Report Underscores How Competition Lowers Prescription Drug Prices by… Read More
DOSE OF REALITY: STUDY FINDS BIG PHARMA’S PATENT THICKETS ON JUST FOUR BRAND NAME DRUGS COST MORE THAN $3.5 BILLION IN TWO YEARS
Sep 3, 2025
Patent Abuse Blocked Competition From More Affordable Alternatives For Periods… Read More
DOSE OF REALITY: BIG PHARMA’S PRICES FOR COSTLIEST 2025 MEDICATIONS OUTPACE FAIR PRICE ESTIMATES BASED ON CLINICAL VALUE
Aug 14, 2025
Highest Priced Brand Name Treatments Showcase Big Pharma’s Rising Launch… Read More
DOSE OF REALITY: REPORT FINDS BIG PHARMA RIDER IN TAX LAW LIKELY TO COST SENIORS AND TAXPAYERS FAR MORE THAN PREVIOUSLY ESTIMATED
Aug 5, 2025
The Wall Street Journal Finds Pharma-Backed Provision Likely to Enable Big… Read More